Clinical Trials Browser

Phase 2 × tebentafusp × 90 days × Clear all

NCT07276386 2026-03-31

Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma

Phase 2 Recruiting

Uveal Melanoma

NCT07057596 2026-03-06

NEO-TB

Phase 2 Recruiting

Melanoma, Neoplasm Metastasis